✦ LIBER ✦

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

✍ Scribed by Yu Jo Chua; Yolanda Barbachano; David Cunningham; Jacqui R Oates; Gina Brown; Andrew Wotherspoon; Diana Tait; Alison Massey; Niall C Tebbutt; Ian Chau

Book ID: 117785238
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 115 KB
Volume: 11
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(09)70381-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

305 Twelve weeks of neoadjuvant capecita

305 Twelve weeks of neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation (CRT) and total mesorectal excision (TME) in MRI defined poor risk locally advanced rectal cancer resulted in promising tumour regression and rapid symptomatic relief

✍ I. Chau; D. Cunningham; D. Tait; G. Brown; N. Tebbutt; M. Hill; A. Wotherspoon; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Preoperative downstaging chemoradiation

Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)

✍ Gollins, S W; Myint, S; Susnerwala, S; Haylock, B; Wise, M; Topham, C; Samuel, L 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 272 KB